Cargando…
Efficacy and safety of perampanel as early add-on therapy in Chinese patients with focal-onset seizures: a multicenter, open-label, single-arm study
BACKGROUND: No interventional study has been conducted in China to assess efficacy and safety of perampanel in treating Chinese patients with epilepsy, nor has there been any study on perampanel early add-on therapy in China. This interventional study aimed to assess efficacy and safety of perampane...
Autores principales: | Gao, Lehong, Lu, Qiang, Wang, Zan, Yue, Wei, Wang, Guoping, Shao, Xiaoqiu, Guo, Yi, Yi, Yonghong, Hong, Zhen, Jiang, Yuwu, Xiao, Bo, Cui, Guiyun, Gao, Feng, Hu, Jiasheng, Liang, Jianmin, Zhang, Meiyun, Wang, Yuping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499319/ https://www.ncbi.nlm.nih.gov/pubmed/37712083 http://dx.doi.org/10.3389/fneur.2023.1236046 |
Ejemplares similares
-
First add‐on perampanel for focal‐onset seizures: An open‐label, prospective study
por: Kim, Ji Hyun, et al.
Publicado: (2019) -
Add-on perampanel in Lance–Adams syndrome
por: Steinhoff, Bernhard J., et al.
Publicado: (2016) -
Efficacy of perampanel as an adjunctive therapy in pediatric focal epilepsy
por: Zhang, Wei-Ran, et al.
Publicado: (2023) -
Successful Treatment of Drug-Resistant Seizures Secondary to Ring 20 Mosaicism with Perampanel as an Add-On Antiepileptic Drug
por: Ling, Janet, et al.
Publicado: (2022) -
Evaluation of perampanel as monotherapy for focal seizures: Experience from open-label extension studies
por: Kwan, Patrick, et al.
Publicado: (2017)